Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Clinics and Research in Hepatology and Gastroenterology|July 29, 2026
Squamous Cell Anal Carcinoma: Current Therapeutic ApproachesValentina Zen, Francesca Bof, Rossana Intini, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|August 19, 2025
MSI-H locally recurrent rectal cancer: Immune checkpoint inhibitors vs. standard chemotherapy and pelvic exenterationLuca Sorrentino, Vincenzo Nasca, Elena Daveri, et al.
Expert Review of Anticancer Therapy|January 18, 2018
The role of tumor angiogenesis as a therapeutic target in colorectal cancerFrancesca Battaglin, Alberto Puccini, Rossana Intini, et al.
Biomed Research International|August 1, 2017
Immunotherapy in Gastrointestinal CancersLetizia Procaccio, Marta Schirripa, Matteo Fassan, et al.
The Oncologist|August 19, 2018
Another Chapter of the Right Versus Left Story: Is Primary Tumor Location a Prognostic Feature in RAS Mutant Metastatic Colorectal Cancer?Fotios Loupakis, Marta Schirripa, Rossana Intini, et al.
Genes|January 23, 2024
Association between Pancreatoblastoma and Familial Adenomatous Polyposis: Review of the Literature with an Additional CaseAndrea Remo, Silvia Negro, Riccardo Quoc Bao, et al.
Critical Reviews in Oncology/Hematology|November 24, 2024
Detecting BRAF mutations in colorectal cancer in clinical practice: An Italian experts' position paperUmberto Malapelle, Valentina Angerilli, Rossana Intini, et al.
The Journal of Pathology|January 9, 2025
Computational pathology applied to clinical colorectal cancer cohorts identifies immune and endothelial cell spatial patterns predictive of outcomeNicholas Trahearn, Chirine Sakr, Abhirup Banerjee, et al.
European Journal of Cancer (Oxford, England : 1990)|July 1, 2022
Prognostic impact of performance status on the outcomes of immune checkpoint inhibition strategies in patients with dMMR/MSI-H metastatic colorectal cancerGiacomo Mazzoli, Romain Cohen, Sara Lonardi, et al.
Journal of Cancer Research and Clinical Oncology|November 7, 2019
Clinical impact of first-line bevacizumab plus chemotherapy in metastatic colorectal cancer of mucinous histology: a multicenter, retrospective analysis on 685 patientsVincenzo Catalano, Francesca Bergamo, Chiara Cremolini, et al.
Pageof 4